Chart calendar Immunovant, Inc.

d36a267831.ia4HkL5ev1RUuwFfzdlVOEuQrOZMSSCuXbGPFuiellw._ullw8oR9BER2llyo41ic3vkgdMhBU6aH-PhfofB0gTl3Crj9QvdCz6Wbg~573139ea708174f966ce8e580b92682f

Upcoming events on Immunovant, Inc.

05/08/2025 Q1 2026 Earnings Release (Projected)
30/10/2025 Q2 2026 Earnings Release (Projected)
17/02/2026 Q3 2026 Earnings Release (Projected)
02/06/2026 Q4 2026 Earnings Release (Projected)

Past events on Immunovant, Inc.

29/05/2025 12:00 Q4 2025 Earnings Release
21/04/2025 13:00 Business Update Call
19/03/2025 12:00 Business Update Call
06/02/2025 11:30 Q3 2025 Earnings Release
14/01/2025 15:30 JP Morgan Healthcare Conference
07/11/2024 13:00 IMVT-1402 Phase 1 Results Call
07/11/2024 11:30 Q2 2025 Earnings Release
01/11/2024 20:05 American Thyroid Association Meeting
09/09/2024 13:00 Business Update Call
12/08/2024 21:00 Annual General Meeting
06/08/2024 21:05 Q1 2025 Earnings Release
29/05/2024 21:01 Q4 2024 Earnings Release
12/02/2024 12:00 Q3 2024 Earnings Release
09/01/2024 15:30 JPMorgan Healthcare Conference
30/11/2023 16:30 Piper Sandler Healthcare Conference
28/11/2023 22:05 Evercore ISI HealthCONx Conference
28/11/2023 13:00 IMVT-1402 Phase 1 Results Call
15/11/2023 18:50 Stifel Healthcare Conference
09/11/2023 12:00 Q2 2024 Earnings Release
26/09/2023 13:00 IMVT-1402 Phase 1 Results Call

Annual results

Fiscal PeriodMarch 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

9,54


64,0


132

EBITDA
Million USD
Released
Forecast
Spread
-218
-186
-17.49%
-282
-259
-8.88%
-438
-479
8.57%

-436


-373


0,00

EBIT
Million USD
Released
Forecast
Spread
-218
-201
-8.6%
-283
-266
-6.12%
-438
-465
5.85%

-517


-544


-585

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-211
-207
-1.82%
-259
-252
-2.85%
-413
-424
2.7%

-510


-581


-573

Net income
Million USD
Released
Forecast
Spread
-211
-205
-2.85%
-259
-250
-3.91%
-414
-446
7.26%

-495


-529


-548

EPS
USD
Released
Forecast
Spread
-1,71
-1,65
-3.72%
-1,88
-1,79
-5.23%
-2,73
-2,85
4.17%

-2,89


-2,88


-2,86

Announcement Date22/05/2329/05/2429/05/25-

Quarterly results

Fiscal PeriodMarch 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00


0,00


0,00


43,2

EBITDA
Million USD
Released
Forecast
Spread
-61,7
-45,4
-35.95%
-61,4
-60,5
-1.55%
-80,8
-57,7
-40.04%
-94,2
-74,6
-26.35%
-116
-97,0
-19.18%
-114
-120
5.05%
-114
-110
-3.42%
























EBIT
Million USD
Released
Forecast
Spread
-61,8
-64,8
4.56%
-61,6
-64,1
4.02%
-80,9
-64,7
-24.94%
-94,3
-80,8
-16.68%
-116
-94,2
-22.9%
-114
-119
4%
-114
-120
5.54%

-123


-129


-135


-142


-130


-135


-140


-102

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-58,2
-65,9
11.64%
-51,5
-65,4
21.2%
-75,1
-65,2
-15.21%
-87,1
-77,3
-12.58%
-109
-89,9
-21.25%
-111
-115
3.4%
-106
-117
9.32%

-118


-124


-130


-137


-126


-131


-136


-98,3

Net income
Million USD
Released
Forecast
Spread
-58,7
-62,9
6.72%
-51,4
-62,4
17.66%
-75,3
-63,0
-19.49%
-87,2
-77,2
-12.9%
-109
-90,0
-21.23%
-111
-114
2.28%
-106
-117
9.07%

-117


-123


-129


-135


-126


-131


-136


-98,3

EPS
USD
Released
Forecast
Spread
-0,45
-0,48
5.35%
-0,36
-0,43
16.71%
-0,52
-0,44
-19%
-0,60
-0,53
-12.77%
-0,74
-0,60
-22.52%
-0,76
-0,72
-5.27%
-0,64
-0,70
8.93%

-0,70


-0,73


-0,75


-0,76


-0,80


-0,83


-0,89


-0,68

Announcement Date09/11/2312/02/2429/05/2406/08/2407/11/2406/02/2529/05/25--------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMVT Stock
  4. Calendar Immunovant, Inc.